financetom
Business
financetom
/
Business
/
MarketAxess Average Daily Volume Rises in November vs Year Ago
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
MarketAxess Average Daily Volume Rises in November vs Year Ago
Dec 4, 2024 6:12 AM

08:37 AM EST, 12/04/2024 (MT Newswires) -- MarketAxess Holdings ( MKTX ) said Wednesday its total average daily volume came in at $44.95 billion in November, up 56% from a year earlier but down 3% compared to October.

Total rates ADV was $30.7 billion in November, up 112% from a year ago, but down 2% compared to October, the company said.

High-grade credit ADV was $6.53 billion in November, compared with $6.52 billion a year earlier, while high-yield credit ADV was $1.31 billion last month, compared to $1.91 billion a year ago, the company said.

MarketAxess ( MKTX ) shares fell more than 3% in recent premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Apple First to Surpass $1 Trillion in Global Brand Value, Kantar Says
Apple First to Surpass $1 Trillion in Global Brand Value, Kantar Says
Jun 12, 2024
08:19 AM EDT, 06/12/2024 (MT Newswires) -- Apple ( AAPL ) has become the first brand to exceed $1 trillion in brand value, Kantar's BrandZ said in a global ranking report Wednesday. The iPhone maker is followed by Alphabet's (GOOG) Google ( GOOG ) at $753.5 billion, Microsoft ( MSFT ) at $712.9 billion, Amazon ( AMZN ) at $576.6...
Bread Financial's Delinquency Rate Rises in May
Bread Financial's Delinquency Rate Rises in May
Jun 12, 2024
08:21 AM EDT, 06/12/2024 (MT Newswires) -- Bread Financial Holdings ( BFH ) reported a May delinquency rate Wednesday of 5.9%, up from 5.5% a year earlier. The net loss rate for the month ended May 31 was 8.8%, up from 8.4% a year earlier, the financial services company said. ...
Dianthus Therapeutics Secures US FDA Approval to Launch Phase 2 Study of DNTH103 in Multifocal Motor Neuropathy
Dianthus Therapeutics Secures US FDA Approval to Launch Phase 2 Study of DNTH103 in Multifocal Motor Neuropathy
Jun 12, 2024
08:17 AM EDT, 06/12/2024 (MT Newswires) -- Dianthus Therapeutics ( DNTH ) said Wednesday that the US Food and Drug Administration has approved an Investigational New Drug application for the launch of its phase 2 trial assessing the efficacy, safety, and tolerability of DNTH103 in 36 patients with multifocal motor neuropathy. Preliminary top-line results will likely be available in H2...
China's CAAM 'does not accept' EU decision on EV tariffs
China's CAAM 'does not accept' EU decision on EV tariffs
Jun 12, 2024
BEIJING, June 12 (Reuters) - The China Association of Automobile Manufacturers (CAAM) deeply regrets and does not accept the European Commission's decision to impose tariffs on Chinese electric vehicles. In comments quoted by state media CCTV the CAAM accused the European Commission of predetermining the results of its investigation and abusing its investigative powers. It said it hopes the EU...
Copyright 2023-2026 - www.financetom.com All Rights Reserved